Your session is about to expire
← Back to Search
Keep It Up! 3.0 for Gonorrhea
Study Summary
This trial compares two ways of delivering an online HIV prevention intervention. One way is through community-based organizations and the other is through a central staff at a university.
- Gonorrhea
- HIV/AIDS
- Chlamydia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the enrollment criterion for this medical trial limited to individuals of a certain age?
"The parameters for enrolment in this clinical trial stipulate that patients must be between the ages of 18 and 34. Additionally, there are 26 different trials available to those younger than 18 years old and 82 studies open to individuals above 65."
Are enrollment slots still available for this research trial?
"Affirmative, clinicaltrials.gov data suggests that this medical research is looking for volunteers to join the trial. This project was first posted on October 9th 2019 and underwent its most recent update in June 7 2022. 5000 individuals are needed from one site of recruitment."
Who is eligible to participate in this trial?
"This medical experiment is attempting to enlist 5000 individuals between 18 and 34 who have gonorrhea. In addition, all participants must be proficient in English, possess a recent HIV negative test result or self-reported non-positive status, and maintain an active email account."
What is the current cohort size for this clinical research?
"Affirmative. According to clinicaltrials.gov, this research study is recruiting participants right now. The trial was first published on October 9th 2019 and has been updated most recently on June 7th 2022; it requires 5000 individuals from one medical institution."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger